Characterization of giant marker and ring chromosomes in a pleomorphic leiomyosarcoma of soft tissue by spectral karyotyping

Oncology Reports

Volumn 28, Issue 2, 2012, Pages 533-538

  Nishio, Jun ^a   Aoki, Mikiko ^a   Nabeshima, Kazuki ^a   Iwasaki, Hiroshi ^a   Naito, Masatoshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Cytogenetics; Leiomyosarcoma; Marker chromosome; Spectral karyotyping

Indexed keywords

DESMIN; DOXORUBICIN; FLUORINE 18; KI 67 ANTIGEN; SMOOTH MUSCLE ACTIN; VIMENTIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CASE REPORT; CHROMOSOME 10P; CHROMOSOME 12Q; CHROMOSOME 17P; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME ANALYSIS; CHROMOSOME MARKER; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE ASSOCIATION; GIANT CHROMOSOME MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; RADIATION DOSE; RING CHROMOSOME; SOFT TISSUE SARCOMA; SPECTRAL KARYOTYPING; THIGH; X CHROMOSOME;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; CYTOGENETIC ANALYSIS; HUMANS; LEIOMYOSARCOMA; MALE; MIDDLE AGED; SOFT TISSUE NEOPLASMS; SPECTRAL KARYOTYPING; THIGH; TUMOR MARKERS, BIOLOGICAL;

EID: 84863465203     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1835     Document Type: Article

References (42)

1. Oda Y, Miyajima K, Kawaguchi K, Tamiya S, Oshiro Y, Hachitanda Y, Oya M, Iwamoto Y and Tsuneyoshi M: Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am J Surg Pathol 25: 1030-1038, 2001. (Pubitemid 32685900)
2. Nicolas MM, Tamboli P, Gomez JA and Czerniak BA: Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Hum Pathol 41: 663-671, 2010.
3. Mertens F, Fletcher CD, Dal Cin P, De Wever I, Mandahl N, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, et al: Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Genes Chromosomes Cancer 22: 16-25, 1998. (Pubitemid 28217802)
4. Mandahl N, Fletcher CD, Dal Cin P, De Wever I, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, et al: Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcomas of soft tissues: a report from the CHAMP Study Group. Cancer Genet Cytogenet 116: 66-73, 2000.
5. Sandberg AA: Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma. Cancer Genet Cytogenet 161: 1-19, 2005.
6. El-Rifai W, Sarlomo-Rikala M, Knuutila S and Miettinen M: DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am J Pathol 153: 985-990, 1998. (Pubitemid 28419051)
7. Wang R, Lu YJ, Fisher C, Bridge JA and Shipley J: Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer 31: 54-64, 2001. (Pubitemid 32274133)
8. Derré J, Lagacé R, Nicolas A, Mairal A, Chibon F, Coindre JM, Terrier P, Sastre X and Aurias A: Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest 81: 211-215, 2001. (Pubitemid 32176385)
9. Evans HL and Shipley J: Leiomyosarcoma. In: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Fletcher CDM, Unni KK and Mertens F (eds). IARC Press, Lyon, pp131-134, 2002.
10. Wang R, Titley JC, Lu YJ, Summersgill BM, Bridge JA, Fisher C and Shipley J: Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Mod Pathol 16: 778-785, 2003. (Pubitemid 37011073)
11. Hu J, Rao UN, Jasani S, Khanna V, Yaw K and Surti U: Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study: Cancer Genet Cytogenet 161: 20-27, 2005. (Pubitemid 41096047)
12. Larramendy ML, Kaur S, Svarvar C, Böhling T and Knuutila S: Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization. Cancer Genet Cytogenet 169: 94-101, 2006. (Pubitemid 44308364)
13. Yang J, Du X, Chen K, Ylipää A, Lazar AJ, Trent J, Lev D, Pollock R, Hao X, Hunt K and Zhang W: Genetic aberrations in soft tissue leiomyosarcoma. Cancer Lett 275: 1-8, 2009.
14. Nishio J, Aoki M, Nabeshima K, Iwasaki H and Naito M: Cytogenetic and molecular cytogenetic findings in giant dediffer entiated liposarcoma of the thigh. Oncol Rep 27: 764-768, 2012.
15. Shaffer LG, Slovak ML and Campbell LJ (eds): ISCN (2009): An International System for Human Cytogenetic Nomenclature. Karger, Basel, 2009.
16. Nishio J, Iwasaki H, Althof PA, Naumann S, Ishiguro M, Haraoka S, Iwashita A, Iwasaki A, Kaku Y, Kaneko Y, et al: Identification of a ring chromosome with spectral karyotyping in a pleural synovial sarcoma. Cancer Genet Cytogenet 160: 174-178, 2005. (Pubitemid 40910054)
17. Nishio J, Iwasaki H, Ohjimi Y, Ishiguro M, Koga T, Isayama T, Naito M and Kikuchi M: Gain of Xq detected by comparative genomic hybridization in elastofibroma. Int J Mol Med 10: 277-280, 2002.
18. Fletcher CDM: Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16: 213-218, 1992.
19. Chen E, O'Connell F and Fletcher CDM: Dedifferentiated leiomyosarcoma: clinicopathological analysis of 18 cases. Histopathology 59: 1135-1143, 2011.
20. Nishio J: Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors. J Biomed Biotechnol 2011: 524067, 2011.
21. Otaño-Joos M, Mechtersheimer G, Ohl S, Wilgenbus KK, Scheurlen W, Lehnert T, Willeke F, Otto HF, Lichter P and Joos S: Detection of chromosomal imbalances in leiomyosarcoma by comparative genomic hybridization and interphase cytogenetics. Cytogenet Cell Genet 90: 86-92, 2000.
22. Levy B, Mukherjee T and Hirschhorn K: Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet 121: 1-8, 2000. (Pubitemid 30665733)
23. Hu J, Khanna V, Jones M and Surti U: Genomic alterations in uterine leiomyosarcomas: potential markers for clinical diagnosis and prognosis. Genes Chromosomes Cancer 31: 117-124, 2001. (Pubitemid 32411037)
24. Gisselsson D, Björk J, Höglund M, Mertens F, Dal Cin P, Akerman M and Mandahl N: Abnormal nuclear shape in solid tumors reflects mitotic instability. Am J Pathol 158: 199-206, 2001. (Pubitemid 32096485)
25. Iwasaki H, Nabeshima K, Nishio J, Jimi S, Aoki M, Koga K, Hamasaki M, Hayashi H and Mogi A: Pathology of soft-tissue tumors: daily diagnosis, molecular cytogenetics and experimental approach. Pathol Int 59: 501-521, 2009.
26. Gisselsson D, Jonson T, Petersén A, Strömbeck B, Dal Cin P, Höglund M, Mitelman F, Mertens F and Mandahl N: Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci USA 98: 12683-12688, 2001. (Pubitemid 33020006)
27. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O and van Kessel AG: Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 14: 8-14, 1995.
28. Nilsson M, Meza-Zepeda LA, Mertens F, Forus A, Myklebost O and Mandahl N: Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int J Cancer 109: 363-369, 2004. (Pubitemid 38252764)
29. Forus A, D'Angelo A, Henriksen J, Merla G, Maelandsmo GM, Flørenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F, et al: Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity. Oncogene 20: 6881-6890, 2001. (Pubitemid 33054105)
30. Ragazzini P, Gamberi G, Pazzaglia L, Serra M, Magagnoli G, Ponticelli F, Ferrari C, Ghinelli C, Alberghini M, Bertoni F, et al: Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol Histopathol 19: 401-411, 2004. (Pubitemid 38443902)
31. Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, Bjerkehagen B, Ohnstad HO, Namløs HM, Wang J, Kristiansen BE and Myklebost O: Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res 66: 8984-8993, 2006. (Pubitemid 44521116)
32. Pérot G, Derré J, Coindre JM, Tirode F, Lucchesi C, Mariani O, Gibault L, Guillou L, Terrier P and Aurias A: Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas. Cancer Res 69: 2269-2278, 2009.
33. Du KL, Ip HS, Li J, Chen M, Dandre F, Yu W, Lu MM, Owens GK and Parmacek MS: Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol 23: 2425-2437, 2003. (Pubitemid 36351024)
34. Wang Z, Wang DZ, Pipes GC and Olson EN: Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA 100: 7129-7134, 2003. (Pubitemid 36706404)
35. Pipes GC, Creemers EE and Olson EN: The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev 20: 1545-1556, 2006. (Pubitemid 43901093)
36. Gill S, Stratton MR, Patterson H, Spurr NK, Fisher C, Gusterson BA and Cooper CS: Detection of transforming genes by transfection of DNA from primary soft-tissue tumours. Oncogene 6: 1651-1656, 1991. (Pubitemid 21924269)
37. Pryor JG, Brown-Kipphut BA, Iqbal A and Scott GA: Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor. Am J Dermatopathol 33: 780-785, 2011.
38. Bellavia D, Checquolo S, Campese AF, Felli MP, Gulino A and Screpanti I: Notch3: from subtle structural differences to functional diversity. Oncogene 27: 5092-5098, 2008.
39. Choong PF, Mandahl N, Mertens F, Willén H, Alvegård T, Kreicbergs A, Mitelman F and Rydholm A: 19p+ marker chromosome correlates with relapse in malignant fibrous histiocytoma. Genes Chromosomes Cancer 16: 88-93, 1996. (Pubitemid 26239125)
40. Larramendy ML, Gentile M, Soloneski S, Knuutila S and Böhling T: Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma? Cancer Genet Cytogenet 187: 1-11, 2008.
41. Dei Tos AP, Maestro R, Doglioni C, Piccinin S, Libera DD, Boiocchi M and Fletcher CDM: Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol 148: 1037-1045, 1996. (Pubitemid 26108241)
42. Hernando E, Charytonowicz E, Dudas ME, Menendez S, Matushansky I, Mills J, Socci ND, Behrendt N, Ma L, Maki RG, et al: The AKT-mTOR pathway plays a critical role in the develop ment of leiomyosarcomas. Nat Med 13: 748-753, 2007. (Pubitemid 46889749)